morph tirzepatide is a New Medication for Diabetes and Weight Loss Tirzepatide (Mounjaro) – Advanced Care

Tirzepatide is a GLP-1 and GIP dual receptor agonist

Common side effects (first 2 to 4 weeks) Nausea and diarrhea are the most frequently reported side effects, affecting roughly 20% to 30% of users during dose escalation

If commercially insured: Both Zepbound and Mounjaro may be available for as little as $25 a month, as long as the commercial insurance plan covers the prescription

Signed in as: [email protected] Optimal Weight and Wellness Blog, your ultimate resource for health, wellness, and weight loss insights

Improves Renal Function: Demonstrates enhanced kidney function in animal models of kidney damage

The dosage of tirzepatide prescribed by our healthcare provider will also impact your results